News & Updates
Filter by Specialty:
Erenumab effective for migraine regardless of aura status
28 Jan 2022
byAudrey Abella
In a post hoc analysis, use of the anti-CGRP* receptor monoclonal antibody erenumab led to reduced migraine frequency and AMSM** days in individuals with migraine with and without a history of aura.
Erenumab effective for migraine regardless of aura status
28 Jan 2022Treatment-resistant hypertension can be monitored using home BP
27 Jan 2022
Home blood pressure monitoring (HBPM) may be a valuable method of monitoring for treatment-resistant hypertension and for subsequent risk stratification, a recent study has found.